Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Sangamo Therapeutics Announces Participation at the Bank of America 2020 Health Care Conference
Sangamo Therapeutics Announces Participation at the Bank of America 2020 Health Care Conference


Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present at the Bank of America 2020 Health Care Conference on Thursday, May 14 at 4:20

Agilent Awards Trilogy Sciences with a Golden Ticket at LabCentral
Agilent Awards Trilogy Sciences with a Golden Ticket at LabCentral


Agilent Technologies Inc. (NYSE: A) announces that biotech startup Trilogy Sciences has been awarded an Agilent Golden Ticket at LabCentral, a leading biotech innovation hub based in Cambridge

DexCom Prices Offering of Upsized $1.05 Billion of 0.25% Convertible Senior Notes
DexCom Prices Offering of Upsized $1.05 Billion of 0.25% Convertible Senior Notes


DexCom, Inc. (Nasdaq: DXCM) (“DexCom”) announced today the pricing of its offering of $1.05 billion aggregate principal amount of 0.25% Convertible Senior Notes due 2025 (the “notes”) in a private

DexCom Prices Offering of Upsized $1.05 Billion of 0.25% Convertible Senior Notes
DexCom Prices Offering of Upsized $1.05 Billion of 0.25% Convertible Senior Notes


DexCom, Inc. (Nasdaq: DXCM) (“DexCom”) announced today the pricing of its offering of $1.05 billion aggregate principal amount of 0.25% Convertible Senior Notes due 2025 (the “notes”) in a private

CymaBay: April-Empfehlung mit +196% Kursgewinn!
CymaBay: April-Empfehlung mit +196% Kursgewinn!

Die Party im No Brainer Club kennt derzeit wieder keine Grenzen. Mit CymaBay Therapeutics (WKN: A116DD) ist der nächste Vervielfacher eingetütet – in kaum mehr als einem Monat!

Die NBC-Experten

Sangamo Therapeutics Reports Business Highlights and First Quarter 2020 Financial Results
Sangamo Therapeutics Reports Business Highlights and First Quarter 2020 Financial Results


Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today reported first quarter 2020 financial results and recent business highlights.



“I’m proud of how the Sangamo team has

Humana Specialty Pharmacy Wins National Award for Third Consecutive Year
Humana Specialty Pharmacy Wins National Award for Third Consecutive Year


Humana Specialty Pharmacy has received the Specialty Pharmacy Patient Choice Award in the PBM/Payer category for the third year in a row. The award, presented by Zitter Health Insights, a division

Humana Announces Additional Bold Goal Communities in Cincinnati and Detroit
Humana Announces Additional Bold Goal Communities in Cincinnati and Detroit


Humana Inc. (NYSE: HUM) announced today that Cincinnati, Ohio and Detroit, Michigan are the latest additions to its Bold Goal communities. The Bold Goal is Humana’s population health strategy to

LivaNova to Present at the UBS Virtual Global Healthcare Conference
LivaNova to Present at the UBS Virtual Global Healthcare Conference


LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced Damien McDonald, Chief Executive Officer, will present at the UBS Virtual Global Healthcare Conference on

DexCom Announces Proposed Offering of $850.0 Million of Convertible Senior Notes
DexCom Announces Proposed Offering of $850.0 Million of Convertible Senior Notes


DexCom, Inc. (Nasdaq: DXCM) (“DexCom”) announced today that it intends to offer, subject to market conditions and other factors, $850.0 million aggregate principal amount of Convertible Senior

DexCom Announces Proposed Offering of $850.0 Million of Convertible Senior Notes
DexCom Announces Proposed Offering of $850.0 Million of Convertible Senior Notes


DexCom, Inc. (Nasdaq: DXCM) (“DexCom”) announced today that it intends to offer, subject to market conditions and other factors, $850.0 million aggregate principal amount of Convertible Senior

NanoString to Present at the Bank of America Health Care Conference
NanoString to Present at the Bank of America Health Care Conference


NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s management is scheduled to present

Quidel Receives Emergency Authorization for Rapid Antigen COVID-19 Diagnostic Assay
Quidel Receives Emergency Authorization for Rapid Antigen COVID-19 Diagnostic Assay


Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel has

DexCom, Inc. Announces Change of Location of Annual Meeting of Stockholders to Be Held May 21, 2020
DexCom, Inc. Announces Change of Location of Annual Meeting of Stockholders to Be Held May 21, 2020


DexCom, Inc. (NASDAQ:DXCM) today announced that, due to the public health impact of the COVID-19 pandemic, the location of the 2020 Annual Meeting of Stockholders of DexCom, Inc. (the “Company”)

DexCom, Inc. Announces Change of Location of Annual Meeting of Stockholders to Be Held May 21, 2020
DexCom, Inc. Announces Change of Location of Annual Meeting of Stockholders to Be Held May 21, 2020


DexCom, Inc. (NASDAQ:DXCM) today announced that, due to the public health impact of the COVID-19 pandemic, the location of the 2020 Annual Meeting of Stockholders of DexCom, Inc. (the “Company”)

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)


Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on May 4, 2020 the Compensation Committee of Puma’s Board of Directors approved the grant of inducement

Acadia Healthcare to Participate in BofA Securities 2020 Health Care Conference
Acadia Healthcare to Participate in BofA Securities 2020 Health Care Conference


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in the BofA Securities 2020 Health Care Conference, which takes place May 12 – 14, 2020. This

Premier Inc. Predictive Technology Helps Prepare for Resumption of Elective Procedures by Identifying Surges in COVID-19 Cases and Supply Needs
Premier Inc. Predictive Technology Helps Prepare for Resumption of Elective Procedures by Identifying Surges in COVID-19 Cases and Supply Needs


Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, is leveraging its technology solutions to help hospitals and health systems across the country anticipate surges in COVID-19

Gilead Sciences: Remdesivir ist leider kein Allheilmittel
Gilead Sciences: Remdesivir ist leider kein Allheilmittel

Gilead Sciences (WKN: 885823) ist, langfristig betrachtet, eine der größten Erfolgsgeschichten im Biotechsektor. So gelang es dem, zwischenzeitlich zu einem Konzern herangewachsenen, Unternehmen

Gilead Sciences: Remdesivir ist leider kein Allheilmittel
Gilead Sciences: Remdesivir ist leider kein Allheilmittel

Gilead Sciences (WKN: 885823) ist, langfristig betrachtet, eine der größten Erfolgsgeschichten im Biotechsektor. So gelang es dem, zwischenzeitlich zu einem Konzern herangewachsenen, Unternehmen

Gilead Sciences: Remdesivir ist leider kein Allheilmittel
Gilead Sciences: Remdesivir ist leider kein Allheilmittel

Gilead Sciences (WKN: 885823) ist, langfristig betrachtet, eine der größten Erfolgsgeschichten im Biotechsektor. So gelang es dem, zwischenzeitlich zu einem Konzern herangewachsenen, Unternehmen

Pfizer Invites Public to View and Listen to Webcast of May 15 Conference Call with Analysts to Review Duchenne Muscular Dystrophy (DMD) Data Presentation at ASGCT 2020 Annual Meeting
Pfizer Invites Public to View and Listen to Webcast of May 15 Conference Call with Analysts to Review Duchenne Muscular Dystrophy (DMD) Data Presentation at ASGCT 2020 Annual Meeting


Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts on Friday, May 15, 2020 at 10:00 a.m. EDT. The purpose

Pfizer Invites Public to View and Listen to Webcast of May 15 Conference Call with Analysts to Review Duchenne Muscular Dystrophy (DMD) Data Presentation at ASGCT 2020 Annual Meeting
Pfizer Invites Public to View and Listen to Webcast of May 15 Conference Call with Analysts to Review Duchenne Muscular Dystrophy (DMD) Data Presentation at ASGCT 2020 Annual Meeting


Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts on Friday, May 15, 2020 at 10:00 a.m. EDT. The purpose

Humana, Papa and Uber Health Join Industry Leaders to Remind Public They’re “Far from Alone” in Combatting Loneliness and Social Isolation
Humana, Papa and Uber Health Join Industry Leaders to Remind Public They’re “Far from Alone” in Combatting Loneliness and Social Isolation


Humana Inc. (NYSE: HUM), in partnership with Uber Health, Papa, Coalition to End Social Isolation and Loneliness, and the NASA-funded Translational Research Institute for Space Health (TRISH) today

Savara Announces Change of Date for 2020 Annual Meeting of Stockholders
Savara Announces Change of Date for 2020 Annual Meeting of Stockholders


Savara Inc. (Nasdaq: SVRA), an orphan lung disease company, today announced a change in the date, time, and format of its 2020 Annual Meeting of Stockholders due to public health and safety